Mutant DNA Polymerases Enhancing Reverse Transcriptase Efficiency
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current DNA polymerases, particularly in PCR and RT-PCR, face challenges in reverse transcriptase efficiency, mismatch tolerance, and inhibitor resistance, which affect the accuracy and efficiency of nucleic acid amplification and extension processes.
Innovation Solution
Development of mutant DNA polymerases with specific amino acid substitutions, such as at positions 616, 580, and 709, that enhance reverse transcriptase efficiency, mismatch tolerance, and resistance to inhibitors, while maintaining DNA-dependent polymerase activity, allowing for improved performance in RT-PCR and PCR applications.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If standard DNA polymerases are used in RT-PCR, then the basic amplification function is achieved, but reverse transcriptase efficiency is insufficient
Solution Approach 1:
The patent applies parameter changes by modifying specific amino acid residues in the DNA polymerase sequence (positions 616, 580, and 709) to alter the enzyme's catalytic properties. These sequence variations optimize the polymerase for reverse transcription while maintaining DNA-dependent polymerase activity, thereby improving reverse transcriptase efficiency without sacrificing amplification accuracy
2Adaptability or versatility
If standard DNA polymerases are used, then the amplification process can proceed, but mismatch tolerance is poor
Solution Approach 1:
The patent modifies specific amino acid parameters in the polymerase sequence to enhance mismatch tolerance. By changing residues at positions 616, 580, and 709, the enzyme gains improved ability to tolerate mismatches during reverse transcription while maintaining sufficient amplification accuracy for diagnostic applications
3Reliability
If standard DNA polymerases are used in the presence of inhibitors, then basic function is maintained, but inhibitor resistance is low
Solution Approach 1:
The patent applies targeted parameter changes by modifying only three specific amino acid positions in the polymerase sequence. This minimal modification approach enhances inhibitor resistance and overall enzyme performance without significantly increasing sequence complexity, making the improved polymerase practical for clinical diagnostics
Solution Approach 2:
The modified polymerase exhibits enhanced self-service capability by inherently resisting inhibitors present in clinical samples. The amino acid modifications enable the enzyme to maintain activity in the presence of inhibitors without requiring additional treatment or purification steps, thereby improving reliability in real-world diagnostic settings
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The mutant DNA polymerases demonstrate increased reverse transcriptase efficiency, improved mismatch tolerance, and enhanced resistance to inhibitors, leading to more accurate and efficient nucleic acid amplification and extension, particularly in the presence of challenging conditions like high temperatures and inhibitor presence.
Implementation Method 1
DNA polymerases function in cells as the enzymes responsible for the synthesis of DNA. They polymerize deoxyribonucleoside triphosphates in the presence of a metal activator, such as Mg2+, in an order dictated by the DNA template or polynucleotide template that is copied.
Implementation Method 2
mismatch tolerance, extension rate and/or tolerance of reverse transcriptase (RT) and polymerase inhibitors
Implementation Method 3
tolerance of reverse transcriptase (RT) and polymerase inhibitors
Data Source
AI summary
Disclosed are DNA polymerases having increased reverse transcriptase efficiency relative to a corresponding, unmodified polymerase. The polymerases are useful in a variety of disclosed primer extension methods. Also disclosed are related compositions, including recombinant nucleic acids, vectors, and host cells, which are useful, e.g., for production of the DNA polymerases.